NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
SRPT Sarepta Therapeutics
- 106.950
- +1.390+1.32%
Close Feb 25 16:00 ET
- 108.040
- +1.090+1.02%
Pre 04:14 ET
10.22BMarket Cap69.45P/E (TTM)
107.105High103.330Low1.07MVolume105.750Open105.560Pre Close113.39MTurnover1.17%Turnover RatioLossP/E (Static)95.52MShares173.25052wk High8.37P/B9.75BFloat Cap101.15052wk Low--Dividend TTM91.14MShs Float181.830Historical High--Div YieldTTM3.58%Amplitude2.598Historical Low106.010Avg Price1Lot Size
About Sarepta Therapeutics Company
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Company Profile
SymbolSRPT
Company NameSarepta Therapeutics
Listing DateJun 4, 1997
Issue Price9.00
Founded1980
CEOMr. Christopher Garabedian
MarketNASDAQ
Employees1314
Fiscal Year Ends12-31
Address215 First Street,Suite 415
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-274-4000
Websitehttp://www.sarepta.com
Company Executives
- Name
- Position
- Salary
- Douglas S. Ingram,Esq.
- Director, President and Chief Executive Officer
- 1.66M
- Ian Michael Estepan
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 3.71M
- Dallan Murray
- Executive Vice President and Chief Customer Officer
- --
- Bilal Arif
- Executive Vice President and Chief Technical Operations Officer
- 3.52M
- Louise Rodino-Klapac
- Executive Vice President, Head of R&D and Chief Scientific Officer
- 3.72M
- Cristin Rothfuss
- Executive Vice President and General Counsel
- --
- Deirdre P. Connelly
- Director
- --
- Dr. Hans Wigzell, M.D.,PhD
- Independent Director
- 546.99K
- Dr. Kathryn Jean Boor, PhD
- Independent Director
- 543.58K
- Dr. Stephen L. Mayo, PhD
- Independent Director
- 546.49K
- Richard J. Barry
- Independent Director
- 563.65K
- Michael Chambers
- Independent Director
- 533.99K
- Dr. Claude Nicaise,M.D.
- Independent Director
- 553.34K
- Dr. M. Kathleen Behrens Wilsey, PhD
- Chairwoman of the Board
- 594.99K